Poniard Pharmaceuticals, Inc.

OTCPK:PARD Stock Report

Market Cap: US$149.0

Poniard Pharmaceuticals Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure16.8yrs

Recent management updates

No updates

Recent updates

No updates


CEO

Poniard Pharmaceuticals has no CEO, or we have no data on them.


Board Members

NamePositionTenureCompensationOwnership
Robert Littauer
Independent Director20.3yrsUS$116.50kno data
Frederick Craves
Director31.2yrsUS$94.00kno data
Alan Glassberg
Member of Clinical Advisory Boardno dataUS$211.67kno data
David Stevens
Independent Director20.3yrsUS$107.00kno data
Robert Basso
Independent Director17.3yrsUS$118.50kno data
Paul A. Bunn
Member of Clinical Advisory Boardno datano datano data
Skip Burris
Member of Clinical Advisory Board16.3yrsno datano data
E. Crawford
Member of Clinical Advisory Board16.3yrsno datano data
Everett Vokes
Member of Clinical Advisory Board16.3yrsno datano data
Robert Ozols
Member of Clincal Advisory Board16.3yrsno datano data
Eric Small
Member of Clinical Advisory Boardno datano datano data
Richard Goldberg
Member of Clinical Advisory Boardno datano datano data

16.8yrs

Average Tenure

78yo

Average Age

Experienced Board: PARD's board of directors are seasoned and experienced ( 16.8 years average tenure).